These data agree with the findings from a study of three independent cohorts by Verberk et al. [34], who found an AUC of 0.87–0.89 for the use of a combination of NfL, p-tau181 and GFAP to distinguish AD and FTD. This evidence concerns the gene NEFL and Alzheimer disease.